Connection

Nathan Peiffer-Smadja to Azithromycin

Back to Details
This is a "connection" page, showing publications Nathan Peiffer-Smadja has written about Azithromycin.
Nathan Peiffer-Smadja
Connection Strength
0.237
Azithromycin
  1. RE: "EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS". Am J Epidemiol. 2020 11 02; 189(11):1443-1444.
    View in: PubMed
    Score: 0.073
  2. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response. Clin Microbiol Infect. 2021 01; 27(1):138-140.
    View in: PubMed
    Score: 0.073
  3. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clin Microbiol Infect. 2021 Jan; 27(1):19-27.
    View in: PubMed
    Score: 0.072
  4. Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response. Clin Microbiol Infect. 2021 06; 27(6):920-921.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.